Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

Helen A. Mintz-Hittner, Kathleen A. Kennedy, Alice Z. Chuang · New England Journal of Medicine · 2011 · 1.5K citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +14

The International Classification of Retinopathy of Prematurity Revisited : An International Committee for the Classification of Retinopathy of Prematurity

Glen A. Gole, Anna L. Ells, Ximena Katz et al. · Archives of Ophthalmology · 2005 · 1.4K citations

Medicine, Ophthalmology, Ocular Disease +8

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology · 2006 · 1.1K citations

Medicine, Ophthalmology, Pharmacotherapy +14

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy

Robert L. Avery, Joel Pearlman, Dante J. Pieramici et al. · Ophthalmology · 2006 · 802 citations

Medicine, Ophthalmology, Pharmacotherapy +13

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

Anne E. Fung, Philip J. Rosenfeld, Elias Reichel · British Journal of Ophthalmology · 2006 · 537 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14